10times
04 Dec 2020Ended

The Evolving Role of PI3K Inhibitors for the Management of Hematologic Malignancies: Integration of Recent Data Sets into Clinical Practice

AboutSpeakersExhibitorsReviewsPhotos

Estimated Turnout

upto 100
Delegates
Based on previous editions

Editions

04 Dec 2020

Frequency

Not Available
Claim event to edit details

The Evolving Role of PI3K Inhibitors for the Management of Hematologic Malignancies: Integration of Recent Data Sets Into Clinical Practice is a .. Read more platform where renowned experts in hematologic malignancies will review the rationale for PI3K inhibitors in the treatment of chronic lymphocytic leukemia and lymphoma, as well as assess the recent clinical trial available. The experts will provide insights on the identification of patients likely to achieve greatest clinical benefit with PI3K inhibitors, the practical implications of utilizing PI3K inhibitors in the clinic, and the impact of PI3K inhibitors on patients with hematologic malignancies.

  • Share your Experience
  • Organizer
Logo Follow Company

Physicians Education Resource Renowned

USA 108 Total Events / 30 Upcoming Events

More Events From The Organizer